CN1371741A - Chinese medicine injection for stopping cancer pain - Google Patents
Chinese medicine injection for stopping cancer pain Download PDFInfo
- Publication number
- CN1371741A CN1371741A CN 02114954 CN02114954A CN1371741A CN 1371741 A CN1371741 A CN 1371741A CN 02114954 CN02114954 CN 02114954 CN 02114954 A CN02114954 A CN 02114954A CN 1371741 A CN1371741 A CN 1371741A
- Authority
- CN
- China
- Prior art keywords
- injection
- herba chelidonii
- mice
- group
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The preparation method of the Chinese medicine injection using celandine as raw material for relieving pain due to cancers includes the following steps: cutting celandine, adding ethyl alcohol, heating-refluxing to make extraction, combining alcohol extract, pressure-reducing and recovering ethyl alcohol and making concentration, using phosphoric acid solution to regulate its pH value to acidity, cold-storing and filtering, using sodium hydroxide solution to regulate pH value of the obtained filtrate to basicity, using isometric trichloromethane to make extraction, combining trichloromethane solution, recovering trichloromethane, vacuum-drying residuum to obtain total alkaloid extract, then adding injection water, stirring and dissolving, using phosphoric acid solution to regulate pH value to acidity, filtering, adidng Tween-80, benzil alcohol and sodium chloride in filtrate, mixing and filtering.
Description
Affiliated technical field
The present invention relates to a kind of medicine that is used for stopping cancer pain, specifically relate to a kind of Chinese medicine injection.
Background technology
Cancerous pain is a general worldwide problem.Effectively pain management especially for patients with advanced cancer, is one of four emphasis in World Health Organization's cancer unified plan.According to World Health Organization (WHO) statistics, the annual de novo cancer patient in the whole world has 7,000,000 approximately at present, and is dead more than 430 ten thousand, wherein 30～50% patients when dead with in various degree pain.Modern medicine is not clear and definite fully as yet to the mechanism that cancer pain produces.
At present, cancer pain still belongs to a kind of disease that is difficult to conquer.Three rescue by stages are recommended to use to the treatment of cancerous pain by World Health Organization (WHO).Mild pain uses the non-opium analgesic, as: acetaminophen, aspirin and ibuprofen, naproxen, piroxicam etc.; Moderate pain then uses weak opium kind analgesics, as: codeine, paracetamol ﹠ codeine, or add nonopioid analgesic and auxiliary medicaments etc.; Severe pain then adopts strong opiates medicine, as: morphine, Dilauid, methadone etc.These strong opiates medicines can make the patient solve temporary transient misery, and spirit is suitably had a rest, and easily produce side effect such as cumulative toxicity and dependency but use continuously.If improper use, the management of mistake more can endanger health of human body and social stability.In recent years, this class medicine Lu's abuse and dependent generation obviously increase, and the serious social problem that brings therefrom becomes increasingly conspicuous, make the clinical practice of this quasi drugs be subjected to strict restriction, cause many cancer pain patients well not treated yet so far, to the processing of cancer pain remain doctors and the stubborn problem of facing.
Summary of the invention
The object of the present invention is to provide a kind of potent low toxicity not have addicted stopping cancer pain Chinese medicine injection.
The Chinese medicine injection that is used for stopping cancer pain provided by the invention, this injection is prepared by following method: be raw material with the Herba Chelidonii, Herba Chelidonii is cut into 0.3～10cm section, 55～95% ethanol that add 4～12 times of amounts, heating and refluxing extraction 1～6 time, each 0.5～5 hour, merge alcohol extract, decompression recycling ethanol and to be concentrated into relative density be 1.05～1.28 is with 0.5～1.5mol/L phosphoric acid solution adjust pH to 1.5～4.5, in 5～10 ℃ of cold preservations 16～72 hours, filter, filtrate is extracted 2～8 times combined chloroform liquid with 5～40% sodium hydroxide solution adjust pH to 9～11.5 with equal amounts of chloroform, reclaim chloroform, the residue vacuum drying gets total alkaloids extract, adds the injection water then, stirring makes dissolving, with 0.5～1.5mol/L phosphoric acid solution adjust pH to 3.0～5.0, filter, filtrate adds tween 80, benzyl alcohol, sodium chloride, mixing filters with 0.3～0.45 μ m microporous filter membrane, add water for injection, embedding, sterilization, promptly.
Herba Chelidonii (Chelidonium majus L.), bitter in the mouth, suffering, slightly warm in nature, poisonous, be bloodroot, main product is in China northeast, the Inner Mongol, Hebei, Henan, Shandong, Shanxi, Jiangsu, Jiangxi, zhejiang and other places.The root of Herba Chelidonii, stem, leaf master contain Chelidonine, wherein contain Chelidonine 0.2～0.4%, protopine 0.04～0.12%, α-allocryptopine 0.01～0.06%, all the other still contain a spot of chelerythrine, Sanguinarine and cryptocavine etc., in addition, also contain choline, histamine, tyramine, Saponin, flavonol, celidoniol and vitamin C, carotene etc.By Herba Chelidonii is the Chinese medicine injection of the present invention that raw material is made, and cancerous pain is had tangible analgesia, calmness, hypnosis and antiinflammatory action.
The present invention is further illustrated below in conjunction with specific embodiment and Pharmacodynamic test of active extract.
Embodiment 1
Get Herba Chelidonii 4000g, be cut into long 2cm section, add 10 times of amount 90% ethanol, heating and refluxing extraction three times each 2 hours, merges alcohol extract, decompression recycling ethanol and to be concentrated into relative density be 1.15 (50 ℃) is with 2mol/L phosphoric acid solution adjust pH to 3.0, in 5 ℃ of cold preservations 24 hours, filter, filtrate is extracted 6 times with equal amounts of chloroform with 30% sodium hydroxide solution adjust pH to 11.0, combined chloroform liquid reclaims chloroform, the residue vacuum drying, get total alkaloids extract, add injection water 800ml then, stir and make dispersion, with 2mol/L phosphoric acid solution adjust pH to 5.0, filter, filtrate adds tween 80 10ml, benzyl alcohol 10ml, sodium chloride 3.45g, mixing, filter with 0.45 μ m microporous filter membrane, add water for injection to 1000ml, embedding, sterilization promptly gets Chinese medicine injection of the present invention.
Embodiment 2
Get Herba Chelidonii 2000g, be cut into long 3cm section, add 8 times of amount 70% ethanol, heating and refluxing extraction three times each 2 hours, merges alcohol extract, decompression recycling ethanol and to be concentrated into relative density be 1.07 (50 ℃) is with 1mol/L phosphoric acid solution adjust pH to 3.5, in 10 ℃ of cold preservations 48 hours, filter, filtrate is extracted 8 times with equal amounts of chloroform with 40% sodium hydroxide solution adjust pH to 10.0, combined chloroform liquid reclaims chloroform, the residue vacuum drying, get total alkaloids extract, add injection water 800ml then, stir and make dispersion, with 1mol/L phosphoric acid solution adjust pH to 3.0, filter, filtrate adds tween 80 11ml, benzyl alcohol 9ml, sodium chloride 5g, mixing, filter with 0.45 μ m microporous filter membrane, add water for injection to 1000ml, embedding, sterilization promptly gets Chinese medicine injection of the present invention.
Embodiment 3
Get Herba Chelidonii 3000g, be cut into the 1cm section, add 6 times of amount 85% ethanol, the heating and refluxing extraction secondary each 2 hours, merges alcohol extract, decompression recycling ethanol and to be concentrated into relative density be 1.10 (50 ℃) is with 1mol/L phosphoric acid solution adjust pH to 2.0, in 10 ℃ of cold preservations 24 hours, filter, filtrate is extracted 4 times with equal amounts of chloroform with 20% sodium hydroxide solution adjust pH to 10.5, combined chloroform liquid reclaims chloroform, the residue vacuum drying, get total alkaloids extract, add injection water 800ml then, stir and make dissolving, with 1mol/L phosphoric acid solution adjust pH to 4.0, filter, filtrate adds tween 80 10ml, benzyl alcohol 10ml, sodium chloride 3.45g, mixing, filter with 0.45 μ m microporous filter membrane, add water for injection to 1000ml, embedding, sterilization promptly gets Chinese medicine injection of the present invention.
Below the 4th～14 page of record be Pharmacodynamic test of active extract of the present invention, Chinese medicine injection wherein of the present invention is called the Herba Chelidonii injection.
The Pharmacodynamic test of active extract summary analgesic experiment of Herba Chelidonii injection shows: Herba Chelidonii injection low dosage (mice 3g/kg, rat 2g/kg) each pain experimental model has all been showed in various degree analgesic activity, the analgesia characteristics are: rapid-action (15min onset), longer duration, dose dependent are obvious; Calm experiment shows: Herba Chelidonii (3-8g/kg) makes free movable minimizing of mice, can work in coordination with the sedative-hypnotic effect of barbital sodium, suppresses the excitation of amfetamine; Antiinflammatory experimental results show that: Herba Chelidonii obviously suppresses mice auricle swelling due to the dimethylbenzene and the rat paw edema due to the Ovum Gallus domesticus album, and suppression ratio reaches more than 40%.The above results shows: the Herba Chelidonii injection has tangible analgesia, calmness, hypnosis, antiinflammatory action.
Test objective
Observe the analgesia of Herba Chelidonii injection, calm, hypnosis and antiinflammatory action, estimate its effect, for the clinical practice of this medicine provides the pharmacology foundation.
Be subjected to the reagent thing
The Herba Chelidonii injection, specification 6.0g crude drug/ml, lot number: 000312, holy territory, Qinghai Pharmaceutical Technology Co., Ltd provides.Compound method (every batch of all fresh preparation of experiment):
Mice
(1) high concentration: get 10ml Herba Chelidonii injection and add injection water 27.5ml (Nanjing, Nanjing Pharmaceutical group company provides lot number: 991002) be diluted to the working solution of 1.6g crude drug/ml, 4 ℃ of preservations.
(2) concentration in: get the high concentration liquid 17.5ml for preparing and add the working solution that injection water 10.5ml is diluted to 1.0g crude drug/ml, 4 ℃ of preservations.
(3) low concentration: get the middle concentration liquid 10ml for preparing and add the working solution that injection water 6.7ml is diluted to 0.6g crude drug/ml, 4 ℃ of preservations.
Packing requirement during each the use, every mice back leg upper outside intramuscular injection amount is 0.1ml.
Rat
(1) high concentration: get 10ml Herba Chelidonii injection and add the working solution that injection water 6ml is diluted to 3.75g crude drug/ml, 4 ℃ of preservations.
(2) concentration in: get the high concentration liquid 8ml for preparing and add the working solution that injection water 5ml is diluted to 2.3g crude drug/ml, 4 ℃ of preservations.
(3) low concentration: get the middle concentration liquid 5ml for preparing and add the working solution that injection water 3ml is diluted to 1.4g crude drug/ml, 4 ℃ of preservations.
Packing requirement during each the use, every rat back leg upper outside intramuscular injection amount is 0.2ml.
The laboratory animal Kunming mouse, body weight 18～22g, animal quality certification 98-022 number; Wistar kind rat, body weight 200 ± 20g, animal quality certification 98-037 number provides by hospital general's pharmacology section of Nanjing Military Command.After animal entered laboratory, male and female were separated, 5 in the every cage of mice, 3 in the every cage of rat, experiment prospective adaptation raising 3 days.Animal housing's illumination abundance is ventilated, and light application time is 12h/ days, and room temperature is controlled at 20～25 ℃, and humidity is 50-70%, routinely sterilization regularly.
The route of administration intramuscular injection, consistent with the clinical application approach of intending recommending.
Experimental control blank: equal-volume water for injection; Positive control: tramadol hydrochloride injection (mice 50mg/kg, rat 25mg/kg).
Experimental data statistical experiment data represent that with x ± s all data are carried out check between variance analysis and group by the SPSS statistical software.
One. Herba Chelidonii injection analgesic test
Dosage is provided with
Do trial test with the mice hot plate method, 3 every group, finding out all mices is 10.5g crude drug/kg to all responseless minimum drug dose of thermostimulation, and the maximum drug dose that all mices all respond to thermostimulation is 1.25g crude drug/kg.In this effective dosage ranges, we get 3,5 respectively, 8g crude drug/kg is as the basic, normal, high dosage of Herba Chelidonii injection mice.By " dosage changes (estimating) calculation scheme between people and various animal and the various animal "
[1], can calculate that the basic, normal, high dosage of rat is about 2.1,3.5 respectively, 5.6g crude drug/kg.
Experiment material
The tramadol hydrochloride injection: thousand sails medicine company limited, lot number: A302J, the date of manufacture: 3/1998, specification: 100mg/2ml.Compound method:
Mice: get 2ml and add injection water 8ml, be diluted to the working solution of 10mg/ml, 4 ℃ of preservations.Get 0.1ml during use in the intramuscular injection of mice back leg upper outside.
Rat: get 2ml and add injection water 4ml, be diluted to the working solution of 16.7mg/ml, 4 ℃ of preservations.Get 0.3ml during use in the intramuscular injection of rat back leg upper outside.
Experimental technique and result
1. mice hot plate method analgesic experiment
[2]
1.1 method is placed on mice on 55 ± 1 ℃ the hot plate, licks the metapedes time as normal pain threshold with mice.The replication secondary, averaging is normal pain threshold (pain threshold before the administration), the screening pain threshold is used for experiment by the mice in 5-30s.Select 60 of qualified mices, random packet.Intramuscular injection various dose Herba Chelidonii injection (totally 3 dosage groups), etc. molten amount normal saline (blank group), tramadol injection (positive controls), each group is by the corresponding dosage administration then.Each group all after administration 15,60,120,240min measures pain threshold respectively once.Mice stops 60s when still not licking metapedes on hot plate, then take out mice immediately, in case soup is hindered, its pain threshold calculates with 60s.Being calculated as follows the threshold of pain and improving percentage rate, is abscissa then with time, and it is vertical coordinate that percentage rate is improved in the threshold of pain, draws time-history curves.
1.2 the result is by table 1 as seen, the 15min onset after administration of Herba Chelidonii injection analgesic activity, and analgesic activity reaches the peak behind the 2h, and analgesic activity is still arranged behind the 4h.Compare with tramadol, though Herba Chelidonii analgesia intensity than tramadol a little less than, analgesia duration is longer than tramadol.
Table 1 Herba Chelidonii injection is to the influence of the mice hot plate method different time threshold of pain (n=10, x ± s)
The different time threshold of pain (s) after the administration before the dosed administration
Group
G crude drug/kg the threshold of pain (s) 15min 60min 120min 240min
Contrast-18.6 ± 3.8 19.4 ± 4.0 20.2 ± 4.2 20.5 ± 4.8 19.6 ± 3.6
Herba Chelidonii 3.00 20.3 ± 3.4 23.5 ± 5.0 24.6 ± 5.6 29.5 ± 7.2
*25.8 ± 8.7
5.00 19.4±4.2 24.2±4.7
* 29.2±7.1
** 35.7±10.3
**?27.6±7.3
**
8.00 19.6±4.5 29.8±8.2
**?34.6±9.1
** 40.4±11.5
**?31.2±8.6
**
Tramadol 0.05 18.8 ± 4.0 32.6 ± 9.6
*45.6 ± 12.0
*34.5 ± 5.5
*21.2 ± 4.4
With before the administration relatively:
*P＜0.05,
*P＜0.01.
2. mice acetic acid twisting experiment
[2]
2.1 50 of method mices, male and female half and half.Grouping and medication are with 1.1.Each organizes all 1h lumbar injection 0.6% acetic acid 0.2ml after administration of mice, observe after 10 minutes and write down mice in 15 minutes turn round the body number of times (with abdominal part shrink, hind leg stretches or buttocks raise be the writhing response positive).And be calculated as follows the writhing response suppression ratio:
2.2 Herba Chelidonii injection 3,5,8g crude drug/kg can significantly suppress the mouse writhing reaction that acetic acid causes as a result, suppression ratio is respectively 51.2%, 68.5%, 78.9%, has certain dose-effect relationship (seeing Table 2).
Table 2 Herba Chelidonii injection is to the influence of mice acetic acid thorn Severe Pain (writhing method) (n=10, x ± s)
(g crude drug/kg) is turned round body number of times suppression ratio (%) P value to group dosage
Contrast-33.8 ± 12.6 0-
Herba Chelidonii 3.00 16.6 ± 6.5 51.2＜0.01
5.00 10.8±5.7 68.5 ＜0.01
8.00 7.3±3.6 78.9 ＜0.01
Tramadol 0.05 4.3 ± 2.2 88.6＜0.01
3. the Herba Chelidonii injection is to the effect of rat trigeminal pain
[3]
3.1 method is got 50 of rats, male and female half and half are divided into 5 groups at random, 10 every group, press table 3 rat dosage intramuscular administration (0.2ml/100g body weight).1h etherization animal after the administration, cut head and neck skin after the cropping, separating muscle, expose the cerebral dura mater between occipital bone and atlas, brain door bolt about 1mm place, lower left (being equivalent to spinal nucleus of trigeminal nerve tail sidepiece) rat, slowly sew up the incision behind potassium penicillin G 3 μ 1 of micro-injection 250,000 u/ml, put in the cage and observe.Screaming, get rid of the number of times sum that head and left and right sides limb grab the homonymy face fast with rat is total attack times, and the righting reflex of record rat recovers in the 40min of back total attack times as the analgesic effect evaluation index.
3.2 the Herba Chelidonii injection has the obvious suppression effect bitterly to rat trigeminal as a result.Dosage from low to high, attack times is respectively 158.3 ± 24.7,106.2 ± 22.8,88.5 ± 26.6 (seeing Table 3).
Table 3 Herba Chelidonii injection is to the influence of rat trigeminal pain (n=10, x ± s)
Group dosage (the total attack times P value of g crude drug/kg)
Contrast-246.7 ± 58.2-
Herba Chelidonii 2.100 158.3 ± 24.7＜0.05
3.500 106.2±22.8 ＜0.01
5.600 88.5±26.6 ＜0.01
Tramadol 0.025 50.7 ± 21.3＜0.01
4. electrostimulation
4.1 method is put into big rat holder with rat, exposes the Mus tail, behind 75% ethanol cleaning afterbody, is coated with conducting resinl and by putting stimulating electrode, carries out square wave electricity irritation (voltage 10v, frequency 1Hz, the wide 10ms of ripple) with pharmacology physiology is many with instrument.It is qualified rat that continuous electric stimulates secondary (5min at interval) responder of all shouting.Select 60 of qualified mices, random packet.Intramuscular injection various dose Herba Chelidonii injection (totally 3 dosage groups), etc. molten amount normal saline (blank group), tramadol injection (positive controls), then each the group by the design dosed administration.Behind the administration 60min, the repetitive nerve stimulation rat stimulates the person that do not shout continuous 2 times, and is effective for analgesic, is calculated as follows the analgesia effective percentage:
4.2 Herba Chelidonii injection 3,5,8g crude drug/kg can significantly suppress the reaction of shouting of rat that electricity irritation causes as a result, suppression ratio is respectively 41.6%, 58.3%, 66.7% (seeing Table 4).
Table 4 Herba Chelidonii injection rat electrostimulation analgesia result (n=12, x ± s)
Group dosage (the analgesia of g crude drug/kg) number of animals analgesia percentage rate (%) P value
Contrast-0 0-
Herba Chelidonii 3.00 5 41.6＜0.05
5.00 7 58.3 ＜0.01
8.00 8 66.7 ＜0.01
Tramadol 0.05 10 83.3＜0.01
Two, the calm test of Herba Chelidonii injection
Test dose is set
By trial test, we find that the Herba Chelidonii injection in the performance analgesic activity, also have good sedation, and along with the increase of analgesic activity dosage, sedation strengthens obviously.Consider that this medicine analgesic activity is that it mainly acts on, therefore, this test dosage adopts the test dose of analgesic activity.
Experiment material
Chlorpromazine hydrochloride, Jintan City, Jiangsu pharmaceutical factory produces, lot number: 9803201.The working solution that is made into 1.56mg/ml with water for injection is standby, 20g mice intramuscular injection 0.1ml during use; Amfetamine, a day rich pharmaceutical factory produces, lot number: 970715, be made into the working solution of 0.5mg/ml, 20g mouse peritoneal injection 0.2ml during use with water for injection; Pentobarbital sodium, Shanghai the 4th pharmaceutical factory produces, lot number: 980874, it is standby to be diluted to 2.5mg/ml with water for injection.
Experimental technique and result
1. the Herba Chelidonii injection is to the influence of spontaneous activity in mice
1.1 method is the influence of index evaluation Herba Chelidonii injection to central nervous system of mice with the general mental status of mice and spontaneous activity.40 of the normal mouses of two forelimbs 15～30 times are praised in screening in 2 minutes before the experiment, and male and female half and half are divided into the basic, normal, high dosage group of blank group and Herba Chelidonii injection at random.Adopt toy recording equipment (the imitative cage method of trembling), the active situation before the mice administration respectively organized in record.Each animal is by each group dosage difference intramuscular injection Herba Chelidonii injection then.The spontaneous activity number of times in the mice 2min respectively organized in 1h, 2h, 3h record after the administration.
1.2 three dosage groups of Herba Chelidonii injection all can obviously suppress the spontaneous activity (with comparing P＜0.05 and P＜0.01 before the administration) of mice as a result, and the blank group does not have significant change (seeing Table 5).The most obvious behind the inhibitory action 1h, disappear substantially behind the 3h.Mice does not see phenomenons such as sialorrhea, amyostasia.
Table 5 Herba Chelidonii injection is to the influence of spontaneous activity in mice (n=10, x ± s)
Movable number of times after the preceding administration of dosed administration (inferior/min)
Group
(g crude drug/kg) is (inferior/min) 1h 2h 3h
Blank-125.8 ± 14.4 130.2 ± 17.7 127.5 ± 15.6 124.8 ± 20.5
Herba Chelidonii low dosage 3.0 122.0 ± 13.6 108.7 ± 12.0
*113.4 ± 11.2 118.7 ± 10.5
Middle dosage 5.0 118.2 ± 10.4 96.8 ± 8.8
*106.5 ± 10.6
*112.5 ± 11.9
High dose 8.0 125.5 ± 13.7 82.8 ± 8.3
*108.5 ± 12.5
*116.7 ± 15.8
Compare with the blank group:
*P＜0.05,
*P＜0.01.
2. the Herba Chelidonii injection is to the influence of pentobarbital sodium syngignoscism
[4-5]
2.1 to the sleeping influence of sleep dosage inducing mouse down of pentobarbital sodium threshold
2.1.1 60 of method mices, male and female half and half are divided into 5 groups at random, 12 every group: model control group, basic, normal, high dosage group of Herba Chelidonii injection and chlorpromazine positive controls.Each group is pressed table 5 dosage im administration.Give every ip in mice pentobarbital sodium 25mg/kg behind the administration 1h, the mice righting reflex loss surpasses the mice number of 1min in the record 15min.
2.1.2 the result shows that 12 mices of matched group (water for injection+pentobarbital sodium) have only 2 sleeping (showing as righting reflex loss), and 12 mices of chlorpromazine matched group (chlorpromazine+pentobarbital sodium) are all sleeping, show the modeling success.The number of mice of the basic, normal, high dosage group righting reflex loss of Herba Chelidonii injection is followed successively by 5,8,10, through x
2Check, basic, normal, high dosage group of Herba Chelidonii injection and model control group relatively have significant difference (P＜0.01).Show that the Herba Chelidonii injection can make the mice number of falling asleep due to the sleep dosage under the pentobarbital sodium threshold obviously increase (seeing Table 6).
Table 6 Herba Chelidonii injection is explained down the sleeping influence (n=12) of sleep dosage inducing mouse to pentobarbital sodium
Group dosage (righting reflex loss number increment rate (%) the P value of g crude drug/kg)
Contrast-2--
Herba Chelidonii 3.0 5 150＜0.01
5.0 8 300 ＜0.01
8.0 10 400 ＜0.01
Chlorpromazine 5.0 (mg/kg) 12 500＜0.01
2.2 to the pentobarbital sodium dosage induced mice influence of the length of one's sleep of above threshold sleeping
2.2.1 every group of Mus number of method is 10, grouping and administration are with experiment 2.1.1.1h after the administration, each organizes ip in mice pentobarbital sodium 40mg/kg, extremely recovers as the length of one's sleep with the mice righting reflex loss, and the length of one's sleep of mice respectively organized in record.
2.2.2 control group mice on average about 1h length of one's sleep as a result, and chlorpromazine control group mice average out to length of one's sleep 4.5h.The basic, normal, high dosage group mice of Herba Chelidonii injection is followed successively by 94.6min, 128.3min, 184.5min the average length of one's sleep, and through variance analysis, basic, normal, high dosage group of Herba Chelidonii injection and model control group relatively have significant difference (P＜0.01).Show the Herba Chelidonii injection can significant prolongation pentobarbital sodium above threshold sleep length of one's sleep (seeing Table 7) due to the dosage.
The dosage induced mice influence of the length of one's sleep (n=10) of above threshold sleeping of table 7 Herba Chelidonii injection
Group dosage ((min) the increment rate length of one's sleep (%) the P value of g crude drug/kg)
Contrast-56.8 ± 17.4--
Herba Chelidonii 3.0 88.6 ± 36.7 56.0＜0.05
5.0 128.3±34.2 125.9 ＜0.01
8.0 184.5±40.4 224.8 ＜0.01
Chlorpromazine 5.0 (mg/kg) 276.5 ± 46.6 386.8＜0.01
3. the Herba Chelidonii injection is to the influence of the excited mice of amfetamine
3.1 60 of method mices, male and female half and half are divided into 6 groups at random, 10 every group.First group is the water for injection matched group; Second group is the amfetamine model group; The the 3rd to five group is the basic, normal, high dosage of Herba Chelidonii injection+amfetamine group, and the 6th group is chlorpromazine+amfetamine positive controls.Each organizes dosage and method is the same.Behind the administration 1h, give every ip in mice amfetamine 5mg/kg, behind the 30min, adopt the movable number of times in the toy activity inventory instrument record mice 2min.
3.2 behind the results model group ip in mice amfetamine, the movable number of times of mice obviously increases (P＜0.01) than control group mice activity number of times, shows the modeling success.Give chlorpromazine in advance, can obviously suppress the excitation of amfetamine mice.Each dosage group of Herba Chelidonii injection and model group relatively all can obviously suppress the movable number of times of mice (P＜0.05 or＜0.01), illustrate that the excitement that the Herba Chelidonii injection causes amfetamine has inhibitory action (seeing Table 8).
Table 8 Herba Chelidonii injection causes the influence (n=10) of mice excitation to amfetamine
(the movable number of times of g crude drug/kg) is (inferior/min) suppression ratio (%) P value for group dosage
Contrast-112.6 ± 17.4--
Model-387.8 ± 51.3--
Herba Chelidonii 3.0 340.5 ± 42.6 12.2＜0.05
5.0 320.3±35.0 17.4 ＜0.01
8.0 271.4±30.3 30.0 ＜0.01
Chlorpromazine 5.0 (mg/kg) 83.5 ± 11.9 78.5＜0.01
Three, the antiinflammatory action of Herba Chelidonii injection
Experiment material
Herba Houttuyniae injectio, 2g/ml, Yaan, Sichuan three nine-day periods after the winter solstice Pharma Inc., lot number 980805.The medicinal liquid that is made into 0.2g/ml with water for injection is standby.Dimethylbenzene, Guangzhou Chemical Reagent Factory, lot number 980108.
Experimental technique and result
1. to the influence of mice dimethylbenzene auricle inflammation
[6]
1.1 method is got 50 of mices, male and female half and half.Be divided into 5 groups at random, press preceding method im administration.Positive control drug is a Herba Houttuyniae injectio.After each organizes administration 45min, the every ear of dimethylbenzene 20 μ l/ is applied to both sides before and after the mouse right ear exterior feature, puts to death mice behind the 30min, mice left and right sides auricle same area homalographic is taken off and weigh with diameter 5mm card punch with cotton balls.With two auricle method of double differences values as the swelling level index, the difference between comparative drug group and matched group, and obtain suppression ratio.
1.2 each test dose group of Herba Chelidonii injection all has obvious suppression effect (seeing Table 9) to mice dimethylbenzene auricle inflammation as a result.
Table 9 Herba Chelidonii injection is to the influence of Mice Auricle dimethylbenzene inflammation (n=10 x ± s)
Group dosage (g/kg) swelling degree (mg)
-Press down swollen rate (%) P value
Contrast-6.91 ± 2.05--
Herba Chelidonii 3.0 6.25 ± 3.32 9.6＞0.05
5.0 5.10±1.68 26.2 ＜0.05
8.0 3.53±2.17 48.9 ＜0.01
Herba Houttuyniae 1.0 3.44 ± 1.85 50.2＜0.01
2. to the influence of rat paw edema due to the Ovum Gallus domesticus album
[7]
2.1 method is got 50 of body weight 180-220g Wistar rats, male and female half and half are divided equally 5 groups at random.Earlier measure the left back sufficient sole of the foot volume of each Mus before the administration with drainage volume device, press table 5 dosage and above-mentioned medication administration, 30min after the administration, in the fresh Ovum Gallus domesticus album 0.05ml/ of left back sufficient plantar subcutaneous injection only, after 1 hour, survey the rat paw volume again, be calculated as follows pedal swelling percentage rate and suppression ratio:
2.2 the Herba Chelidonii injection has remarkable inhibitory action (seeing Table 10) to rat Ovum Gallus domesticus album pedal swelling as a result.
Table 10 Herba Chelidonii injection is to the influence of rat Ovum Gallus domesticus album pedal swelling (n=10, x ± s)
Group dosage (g/kg) swelling percentage rate (%, suppression ratio (%) the P value of x ± s)
Contrast 69.7 ± 15.3--
Herba Chelidonii 2.1 58.7 ± 12.2 15.8＞0.05
3.5 53.8±11.7 22.8 ＜0.05
5.6 40.9±10.5 41.3 ＜0.01
Herba Houttuyniae 0.7 34.2 ± 9.1 50.9＜0.01 conclusion, 1. Herba Chelidonii injection have significant analgesia role bitterly to mouse skin Spurs pain, acetic acid peritoneum thorn Severe Pain, electricity irritation pain and rat trigeminal.Characteristics are: rapid-action, the length of holding time has dose dependent.2. the Herba Chelidonii injection has sedation, can suppress the spontaneous activity of normal mouse, increases the pentobarbital sodium hypnosis time, and is inhibited to the excited mice of amfetamine.3. the Herba Chelidonii injection also has antiinflammatory action
Claims (1)
1, a kind of Chinese medicine injection that is used for stopping cancer pain, this injection is prepared by following method: be raw material with the Herba Chelidonii, Herba Chelidonii is cut into 0.3～10cm section, 55～95% ethanol that add 4～12 times of amounts, heating and refluxing extraction 1～6 time, each 0.5～5 hour, merge alcohol extract, decompression recycling ethanol and to be concentrated into relative density be 1.05～1.28 is with 0.5～1.5mol/L phosphoric acid solution adjust pH to 1.5～4.5, in 5～10 ℃ of cold preservations 16～72 hours, filter, filtrate is extracted 2～8 times combined chloroform liquid with 5～40% sodium hydroxide solution adjust pH to 9～11.5 with equal amounts of chloroform, reclaim chloroform, the residue vacuum drying gets total alkaloids extract, adds the injection water then, stirring makes dissolving, with 0.5～1.5mol/L phosphoric acid solution adjust pH to 3.0～5.0, filter, filtrate adds tween 80, benzyl alcohol, sodium chloride, mixing filters with 0.3～0.45 μ m microporous filter membrane, add water for injection, embedding, sterilization, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021149542A CN1141137C (en) | 2002-03-13 | 2002-03-13 | Chinese medicine injection for stopping cancer pain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021149542A CN1141137C (en) | 2002-03-13 | 2002-03-13 | Chinese medicine injection for stopping cancer pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1371741A true CN1371741A (en) | 2002-10-02 |
| CN1141137C CN1141137C (en) | 2004-03-10 |
Family
ID=4743375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021149542A Expired - Fee Related CN1141137C (en) | 2002-03-13 | 2002-03-13 | Chinese medicine injection for stopping cancer pain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1141137C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008017206A1 (en) * | 2006-08-02 | 2008-02-14 | Jin, Zhenglv | A percutaneous intratumoral injection composition for treating thyroma |
| CN108697749A (en) * | 2016-02-08 | 2018-10-23 | 蒙迪亚斯生物有限公司 | Herbal-composition for preventing and treating plant or nail infection and method |
| CN115054664A (en) * | 2022-07-25 | 2022-09-16 | 北京康恩泰生物医药有限公司 | A pharmaceutical composition for treating cancer pain, and its preparation method |
-
2002
- 2002-03-13 CN CNB021149542A patent/CN1141137C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008017206A1 (en) * | 2006-08-02 | 2008-02-14 | Jin, Zhenglv | A percutaneous intratumoral injection composition for treating thyroma |
| CN108697749A (en) * | 2016-02-08 | 2018-10-23 | 蒙迪亚斯生物有限公司 | Herbal-composition for preventing and treating plant or nail infection and method |
| CN115054664A (en) * | 2022-07-25 | 2022-09-16 | 北京康恩泰生物医药有限公司 | A pharmaceutical composition for treating cancer pain, and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1141137C (en) | 2004-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1203857C (en) | Method for localized anesthesia and analgesia | |
| CN1087516A (en) | Pharmaceutical composition and be used for the treatment of the method for junkie withdrawal syndrome and withdrawal | |
| CN1720058A (en) | Development of an anti-cough, anti-tussive and throat soothing herbal formulation | |
| CN1546027A (en) | Dripping pills for treating allergic disease and its preparation process | |
| CN1141137C (en) | Chinese medicine injection for stopping cancer pain | |
| CN101045051A (en) | Novel use of tizanidine or its derivatives | |
| CN1879766A (en) | Medicine for treating rheumatism and preparation method thereof | |
| CN1136931A (en) | Ant ginseng oral liquid and preparing process thereof | |
| CN1824086A (en) | Health protection capsule | |
| CN1136908C (en) | Antalgic medicine for cancerous pain and its preparing process | |
| CN100335090C (en) | Medicinal composition for tonifying kidney and eliminating obstruction, and its preparing method | |
| CN1278734C (en) | Pharmaceutical composition for stopping drug addiction and its preparing process | |
| CN1197580C (en) | Medicine containing fritillary total alkali for treating disease of respiratory system and its preparing method | |
| CN1231233C (en) | Drug addiction stopping machine medicine and its prepn | |
| CN1234403C (en) | Chinese medicine for treating gastric disease | |
| CN1562297A (en) | Combination of Chinese traditional medicine for curing vascular dementia and preparation method | |
| CN1110598A (en) | Hot application for stopping cancer pain | |
| CN1939398A (en) | Use of gentiin in analgesic for treating arthritis | |
| CN1864748A (en) | Preparation of dopamine agonist and application thereof | |
| CN100349567C (en) | (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application | |
| CN1679800A (en) | Medicine for treating oral exulceratio and periodontal turgescene, and preparation thereof | |
| CN1813732A (en) | External-use formulation of fexofenadine | |
| CN1931256A (en) | Chinese medicine capsule for eliminating drug addiction and its prepn process | |
| CN100350937C (en) | Traditional Chinese medicinal composition for treating insomnia and its preparing process | |
| CN1799616A (en) | Gastric ulcer treatment medicine, its preparation process and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |